Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : RECY Looking Good... A -- Ignore unavailable to you. Want to Upgrade?

To: David Graham who wrote (3819)	1/16/1998 12:24:00 PM
From: majormember	Read Replies (1) \| Respond to of 7006

Grammy, I'm happy for you. I, on the other hand did not wait. After all they had clearence for Phase III clinicals; the YAG.Holmium has been around a while, almost assuring FDA approval. I had known about the financing before the announcement. I have spoken to Dr.'s involved in the clinicals, and by ALL accounts this is going to be one of, probably the best of the treatments for hyperopia. What reason could I have thought of that would make me think the price was going lower? It is the favorite stock of Red Chip Analyst Johnny Svoren, and got an excellant write up in PENN. Merchant Group. Hyperopia makes up 31% of the population, and they have more disposible income for this type of procedure then the myopics who are younger have for the excimer laser. I have bought in the 4's and again now in the 3's. Grammy, tell me please, what did you see or know a few months ago that told you to wait... I would love to know. Also, do you not beleive this to be a $35 stock by 2000 when FDA approved? If so, buying in the 4's will make me seem like a genious. Right now I'm not looking too smart... Into RECY high, APCO high, FAMH high and now SNRS high... Hopefully by 1999 I'll be looking smarter. I hope you are having a better year... Skane